Correlation Between Design Therapeutics and Zoetis
Can any of the company-specific risk be diversified away by investing in both Design Therapeutics and Zoetis at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Design Therapeutics and Zoetis into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Design Therapeutics and Zoetis Inc, you can compare the effects of market volatilities on Design Therapeutics and Zoetis and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Design Therapeutics with a short position of Zoetis. Check out your portfolio center. Please also check ongoing floating volatility patterns of Design Therapeutics and Zoetis.
Diversification Opportunities for Design Therapeutics and Zoetis
-0.43 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Design and Zoetis is -0.43. Overlapping area represents the amount of risk that can be diversified away by holding Design Therapeutics and Zoetis Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Zoetis Inc and Design Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Design Therapeutics are associated (or correlated) with Zoetis. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Zoetis Inc has no effect on the direction of Design Therapeutics i.e., Design Therapeutics and Zoetis go up and down completely randomly.
Pair Corralation between Design Therapeutics and Zoetis
Given the investment horizon of 90 days Design Therapeutics is expected to generate 5.62 times more return on investment than Zoetis. However, Design Therapeutics is 5.62 times more volatile than Zoetis Inc. It trades about 0.12 of its potential returns per unit of risk. Zoetis Inc is currently generating about 0.04 per unit of risk. If you would invest 532.00 in Design Therapeutics on September 5, 2024 and sell it today you would earn a total of 67.00 from holding Design Therapeutics or generate 12.59% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Design Therapeutics vs. Zoetis Inc
Performance |
| Timeline |
| Design Therapeutics |
| Zoetis Inc |
Design Therapeutics and Zoetis Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Design Therapeutics and Zoetis
The main advantage of trading using opposite Design Therapeutics and Zoetis positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Design Therapeutics position performs unexpectedly, Zoetis can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Zoetis will offset losses from the drop in Zoetis' long position.| Design Therapeutics vs. Candel Therapeutics | Design Therapeutics vs. Cingulate Warrants | Design Therapeutics vs. Unicycive Therapeutics | Design Therapeutics vs. Cardio Diagnostics Holdings |
| Zoetis vs. Crinetics Pharmaceuticals | Zoetis vs. Enanta Pharmaceuticals | Zoetis vs. Amicus Therapeutics | Zoetis vs. Connect Biopharma Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Other Complementary Tools
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |